JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB203214

Anti-PRKAG3 antibody

Be the first to review this product! Submit a review

|

(1 Publication)

Rabbit Polyclonal PRKAG3 antibody. Suitable for IHC-P and reacts with Human samples. Cited in 1 publication. Immunogen corresponding to Synthetic Peptide within Human PRKAG3 aa 150-250 conjugated to Keyhole Limpet Haemocyanin.

View Alternative Names

AMPKG3, PRKAG3, 5'-AMP-activated protein kinase subunit gamma-3, AMPK gamma3, AMPK subunit gamma-3

1 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PRKAG3 antibody (AB203214)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PRKAG3 antibody (AB203214)

Immunohistochemical analysis of formalin-fixed, paraffin-embedded Human rectal carcinoma tissue labeling PRKAG3 with ab203214 at 1/200 dilution, followed by conjugation to the secondary antibody and DAB staining.

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

IHC-P

applications

Immunogen

Synthetic Peptide within Human PRKAG3 aa 150-250 conjugated to Keyhole Limpet Haemocyanin. The exact immunogen used to generate this antibody is proprietary information.

Q9UGI9

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/100 - 1/500", "IHCP-species-notes": "<p>(or 1/50 - 1/200 using a fluorescent secondary antibody).</p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.4 Preservative: 0.02% Proclin 300 Constituents: 50% Glycerol (glycerin, glycerine), 48.98% TBS, 1X, 1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

PRKAG3 also known as AMP-activated protein kinase subunit gamma-3 is a regulatory subunit of the AMP-activated protein kinase (AMPK) complex. The gamma-3 subunit contributes to the full AMPK function particularly its sensitivity to energy status changes within cells. This subunit weighs approximately 38.1 kDa and is mainly expressed in skeletal muscle tissue. It plays an important role in cellular energy homeostasis by responding to depletion in intracellular ATP levels.
Biological function summary

PRKAG3 interacts with AMP and ADP which activates AMPK when energy levels are low. It forms a complex with two other subunits the alpha (catalytic) and beta (regulatory) subunits to become fully active. Once activated AMPK executes various cellular functions including the regulation of glucose uptake and fatty acid oxidation primarily within muscle tissues which is essential for maintaining energy balance.

Pathways

PRKAG3 takes part in the AMPK signaling pathway a central regulator of metabolic pathways that maintain cellular energy balance. It connects to glucose and lipid metabolic processes interacting with proteins like ACC (acetyl-CoA carboxylase) for fatty acid synthesis inhibition and GLUT4 (glucose transporter type 4) for glucose uptake enhancement. Through these interactions PRKAG3 influences critical metabolic adaptations to energy stress.

Mutations or dysregulation in PRKAG3 have links with glycogen storage disease type V (McArdle disease) and insulin resistance. In particular disorders in glycemic control connect this protein to the regulation of glucose metabolism. PRKAG3 mutations can affect the typical glycogen synthesis and breakdown in skeletal muscle impacting energy availability during exercise. Additionally its activity has associations with insulin-signaling networks in conjunction with proteins like insulin receptor substrate-1 (IRS-1) impacting glucose homeostasis and insulin sensitivity.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

AMP/ATP-binding subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism (PubMed : 14722619, PubMed : 17878938, PubMed : 24563466). In response to reduction of intracellular ATP levels, AMPK activates energy-producing pathways and inhibits energy-consuming processes : inhibits protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation. AMPK acts via direct phosphorylation of metabolic enzymes, and by longer-term effects via phosphorylation of transcription regulators. AMPK also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton; probably by indirectly activating myosin. The AMPK gamma3 subunit is a non-catalytic subunit with a regulatory role in muscle energy metabolism (PubMed : 17878938). It mediates binding to AMP, ADP and ATP, leading to AMPK activation or inhibition : AMP-binding results in allosteric activation of alpha catalytic subunit (PRKAA1 or PRKAA2) both by inducing phosphorylation and preventing dephosphorylation of catalytic subunits. ADP also stimulates phosphorylation, without stimulating already phosphorylated catalytic subunit. ATP promotes dephosphorylation of catalytic subunit, rendering the AMPK enzyme inactive.
See full target information PRKAG3

Publications (1)

Recent publications for all applications. Explore the full list and refine your search

Cellular and molecular life sciences : CMLS 81:265 PubMed38880863

2024

Disturbed glycolipid metabolism activates CXCL13-CXCR5 axis in senescent TSCs to promote heterotopic ossification.

Applications

Unspecified application

Species

Unspecified reactive species

Yuyu Chen,Jinna Wu,Chipiu Wong,Wenjie Gao,Xiangdong Qi,Hang Zhou
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com